Rare Pregnancy Infections Linked to Tripled Autism Risk in Children, Swedish Study Finds
A major Swedish study of 3.7 million people found that rare TORCH infections passed from pregnant women to fetuses are linked to much higher risks of autism and intellectual disability in children later in life.
What Happened
A groundbreaking Swedish study analyzing data from 3.7 million people has identified a significant association between rare TORCH infections transmitted from pregnant women to their fetuses and substantially elevated risks of autism spectrum disorder and intellectual disability in offspring. TORCH is an acronym referring to five congenital infections: Toxoplasmosis, Other (including syphilis), Rubella, Cytomegalovirus, and Herpes simplex virus.
The Study's Key Findings
The research, published in early September 2026, found that children with congenital TORCH infections faced dramatically higher odds of developing autism compared to the general population. The study followed children from birth through adulthood, tracking diagnoses and outcomes. Intellectual disability was also significantly elevated in this group. The size and longitudinal nature of the Swedish cohort made this one of the most comprehensive examinations of this connection to date.
Clinical and Public Health Implications
These findings underscore the critical importance of prenatal screening and infection prevention during pregnancy. TORCH infections, while individually rare, collectively represent a preventable cause of developmental disability. The results support existing recommendations for prenatal testing and may prompt additional screening recommendations. Early detection of maternal infections could allow for treatment interventions that reduce transmission risk to the fetus.
Next Steps and Prevention
Public health authorities in Sweden and internationally are expected to review these findings and potentially strengthen prenatal screening protocols. Pregnant women and healthcare providers should remain vigilant about screening for these infections, particularly in the early stages of pregnancy when intervention is most effective. The research highlights the need for continued investment in prenatal care and infection prevention education.